WithdrawnNot Applicable

Validation of a New Hand Held Light Emitting Diode Device for the Determination of Minimal Erythema Dose (MED)

Stopped: study did not start

United States0Started 2012-05

Plain-language summary

The purpose of this study is to validate a new hand held light emitting diode (LED) device for the measurement of minimal erythema dose (MED) for narrow band Ultraviolet B (UVB) radiation by comparing to the traditional approach of measurement of the minimal erythema dose.

Who can participate

Age range18 Years – 120 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Pregnancy
✕. Lactation
✕. History of photosensitivity disorder
✕. Photosensitizing medications
✕. Personal history of melanoma or non-melanoma skin cancer.
✕. Skin disease on the back

What they're measuring

Minimal Erythema Dose

Timeframe: 1 day

Trial details

NCT IDNCT01818154

SponsorHenry Ford Health System

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-12

View on ClinicalTrials.gov More Phototherapy trials